CDEK
← All organizations

Blue Earth Diagnostics

For profitContributed to NMEWebsite ↗

Also known as: BLUE EARTH | Blue Earth Diagnostics | Blue Earth Diagnostics, Inc | Blue Earth Diagnostics Ltd

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2015

First marketed drug

May 27, 2016

First NDA

May 27, 2016

Last known activity

Dec 31, 2025

Acquired by Bracco on Jun 27, 2019

Timeline

2010s

  1. Mar 1, 2014

    Blue Earth Diagnostics— Founded

  2. May 27, 2016

    Fluciclovine— NDA Organization

  3. May 27, 2016

    Fluciclovine— NDA Secondary Org

  4. Jun 27, 2019

    Bracco— Acquired By

2020s

  1. May 25, 2023

    Flotufolastat— Marketing Organization

Drugs by trial phase (7 distinct, 35 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Recent trials (36)

Details

Founded
Oxford, GB Mar 1, 2014
First NDA
May 27, 2016
Last known activity
Dec 31, 2025

Designations held

  • Priority review